Oestrogen receptors in primary breast cancer Sir -We read with interest the recent article by Alanko et al. (1984) reporting no significant correlation between oestrogen receptor status in primary breast cancer and disease free interval. These findings were based on 263 consecutive patients with a minimum follow-up of 24 months.
Our results on a series of 643 patients with a follow-up of 4-10 years are at variance with their findings. The series is similar in that only 26 patients have received adjuvant chemotherapy. A previous communication from our unit reported an overall correlation between ER status and diseasefree interval (Blamey et al., 1980) . This correlation is not maintained with longer follow-up. A strong relationship also existed between tumour grade and disease-free interval at that time. There remains a strong relationship between grade and disease-free interval and also between tumour grade and oestrogen receptor status of the primary tumour (Table I) .
After stratification of our patients according to lymph node status we continue to observe a significant relationship between DFI and ER status in those patients lymph node positive at mastectomy. This is not seen in node negative patients (Figure 1 ). This relationship has been maintained over 5-10 year of follow-up. We also continue to find a significant correlation between survival and ER status in those patients lymph node positive at mastectomy; again this is not seen in node negative patients (Figure 2 We have previously reported an association between the site of first metastases and ER status. ER positive patients preferentially metastasise to bone (Campbell et al., 1981) . We suggest that this early finding of a relationship between disease-free interval and ER status, before stratification according to node positivity, may in part be due to the consistently short disease-free interval in those patients presenting with visceral metastases associated with ER (1980) are not identical with ours despite the fact that in both studies this point had been accounted for. The main difference is that Blamey et al. (1980) find that in patients with node involvement oestrogen receptor positive tumours
